We are live on ! Find out more
CLGN icon

CollPlant Biotechnologies
CLGN

6 hedge funds and large institutions have $6.28M invested in CollPlant Biotechnologies in 2020 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

151% more capital invested

Capital invested by funds: $2.5M → $6.28M (+$3.78M)

50% more funds holding

Funds holding: 4 → 6 (+2)

0.47% more ownership

Funds ownership: 0.5% → 0.97% (+0.47%)

Holders
6
Holders Change
+2
Holders Change %
+50%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MIH
Meitav Investment House
Israel
+$3.21M
2
SDJVC
St. Denis J. Villere & Co
Louisiana
+$183K
3
IMOV
Investment Management of Virginia
Virginia
+$175K
4
Renaissance Technologies
Renaissance Technologies
New York
+$131K
5
UBS Group
UBS Group
Switzerland
+$7.21K

Top Sellers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$32K

CLGN Hedge Fund Activity: Q2 2020 in Review

6 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in CollPlant Biotechnologies (CLGN) for Q2 2020, worth a combined $6.28M — up 151% from $2.5M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new CLGN positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Meitav Investment House, adding an estimated $3.21M. The largest seller was Acadian Asset Management, exiting entirely with an estimated $32K sold.

  • 6 institutional investors held CollPlant Biotechnologies (CLGN) as of Q2 2020, up from 4 in Q1 2020.
  • Funds reported $6.28M of CollPlant Biotechnologies stock for Q2 2020, up 151% quarter-over-quarter.
  • 3 funds opened new CollPlant Biotechnologies positions in Q2 2020 and 1 closed out, a net change of +2 holders.
  • The largest CollPlant Biotechnologies buyer in Q2 2020 was Meitav Investment House, an estimated $3.21M added.
  • The largest CollPlant Biotechnologies seller in Q2 2020 was Acadian Asset Management, an estimated $32K sold.

Based on aggregated 13F filings for Q2 2020.